They have been used, for example, to treat depression (Wachtel, 1983; Horowski, 1985) and the related PDE4 inhibitor roflumilast has FDA approval for treatment of symptoms of chronic obstructive pulmonary disorder by oral delivery (Wedzicha et al., 2016). The gene discussed is PDE4A; the disease is major depressive disorder.